List of treatments being trialled Part 2!(December 2012 edition)

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • rdawg
    Senior Member
    • Jun 2012
    • 996

    #31
    Originally posted by hellouser

    Also, rdawg, I remember reading a comment by a member here on this forum whos a pharmacist, he mentioned that applications for approvals from the FDA can be made during Phase III.
    If that's the case you can chop off a few months.

    The problem is getting all the patients in a timely manner as well so Phase III may not begin until the summer.

    so yea if what you say is true, Christmas 2014 is very possible.

    Comment

    • 2020
      Senior Member
      • Jan 2012
      • 1513

      #32
      Originally posted by Desmond84
      Well,

      1) Hygeia Pharmaceuticals -> Investigating a topical anti-androgen that degrades upon systemic absorption. (About to start Phase 1)
      there is always RU and CB which block pretty much 100% dht. Is that not enough for you?

      Originally posted by Desmond84
      2) Gliamed -> Regenerative medicine (About to Start Phase 1)
      yeah that sounded promising the first time I've read it but it doesn't really apply to our case - "regenerate" is not for those with androgenic alopecia but with actual scars in places where follicles grows. Yes, apparently along with scar repair, follicles come back to life also but it likely won't work for AA cases.

      Originally posted by Desmond84
      3) Autologous Human Platelet Lysate
      this is a hair transplant boost


      Histogen is all we got!!! It's pathetic reading you all discussing Aderans as if there is ANY CHANCE that it would work... There is none. Forget about it

      Comment

      • clarence
        Senior Member
        • Sep 2012
        • 278

        #33
        Originally posted by hellouser
        Also, rdawg, I remember reading a comment by a member here on this forum whos a pharmacist, he mentioned that applications for approvals from the FDA can be made during Phase III.
        Joy to the world. What keeps this from being released earlier in some country which doesn't have FDA?

        Comment

        • Kirby_
          Senior Member
          • Jan 2012
          • 439

          #34
          Originally posted by 2020
          there is always RU and CB which block pretty much 100% dht. Is that not enough for you?
          Experimental treatments... Only a very small minority is willing to use those, if they have heard of them/have the expertise to use them. The more treatments on the legit market in the future, the better.

          Histogen is all we got!!!
          Well, I agree that it's too early to 'count on' any of these in-development treatments ever emerging as full products, as if its inevitable (we all know the history here) but it's hardly impossible that at least one or two will make it.

          Comment

          • rdawg
            Senior Member
            • Jun 2012
            • 996

            #35
            Originally posted by 2020

            Histogen is all we got!!! It's pathetic reading you all discussing Aderans as if there is ANY CHANCE that it would work... There is none. Forget about it

            Comment

            • Pate
              Senior Member
              • Sep 2011
              • 417

              #36
              Originally posted by 2020
              there is always RU and CB which block pretty much 100% dht. Is that not enough for you?
              RU will never reach market. Too unstable and the patents are too close to expiry, and too unsafe around women.

              CB may reach market, but it's not certain. A lot could still go wrong, both technologically (effectiveness, finding a vehicle) and most importantly financially (Cosmo might get bought out and CB would get shelved like so many other drugs that had potential). So it's good to have this HYG-440 as a back up.

              yeah that sounded promising the first time I've read it but it doesn't really apply to our case - "regenerate" is not for those with androgenic alopecia but with actual scars in places where follicles grows. Yes, apparently along with scar repair, follicles come back to life also but it likely won't work for AA cases.
              They specifically cite MPB as one of their primary purposes. Their aim is to differentiate stem cells into hair cells. We know from Cotsarelis that the stem cells are still there in MPB. So if it works at all, it should work for MPB.


              Histogen is all we got!!! It's pathetic reading you all discussing Aderans as if there is ANY CHANCE that it would work... There is none. Forget about it
              Aderans works. Just not very well, and only in 60% of people. On the results I've seen so far I wouldn't pay for it. The best use for it so far is to add density to make HT grafts go further.

              Comment

              • The Alchemist
                Senior Member
                • Mar 2011
                • 261

                #37
                Originally posted by rdawg
                If they hit Phase III this year(which they should) It will not take longer than a year and a half-2 years until release.

                It's my understanding that Phase III is no longer about if the product is safe/ works to the fullest extent, but rather that they know it works, have the final solution, but want to see if it works on a grand scale(with numerous people).

                So basically what I'm saying is late 2015-2016 or this product doesnt get released at all, it's not that far away.

                Yes, phase III is predominantly about how well their procedure works in a large, heterogeneous group of trialists. In effect, they're attempting to mimic the diversity of patients they'll treat when the product goes to market. This way they (hopefully) uncover any idiosyncratic adverse events that could come up and they'll know the true overall efficacy.

                I don't think aderans results look too bad. I'd like to see what they can do for someone who's just beginning to bald or someone who's diffuse. They might get much better results. However, a 60% responder rate is very low. Hopefully they're continuing research to figure out why the response rate is so low and can find a way to improve on that number.

                Finding out you're in the 40% non responder group would be quite a bitter pill to take.

                Comment

                • rdawg
                  Senior Member
                  • Jun 2012
                  • 996

                  #38
                  Originally posted by The Alchemist
                  I don't think aderans results look too bad. I'd like to see what they can do for someone who's just beginning to bald or someone who's diffuse. They might get much better results. However, a 60% responder rate is very low. Hopefully they're continuing research to figure out why the response rate is so low and can find a way to improve on that number.

                  Finding out you're in the 40% non responder group would be quite a bitter pill to take.
                  Aderans is not about growth, or at least at this point, that isn't there goal. The reason for the 60% response rate is simply due to genetics. Only 60% of these people have genetics that can respond and make these hair follicles immune.

                  In essence, it's a much better alternative to Fin that permanently makes your hair immune to MPB. Mix it with Histogen and you could get great results.

                  Comment

                  • clandestine
                    Senior Member
                    • Aug 2011
                    • 2002

                    #39
                    Replistoderans, ideally.

                    Comment

                    • The Alchemist
                      Senior Member
                      • Mar 2011
                      • 261

                      #40
                      Originally posted by rdawg
                      Aderans is not about growth, or at least at this point, that isn't there goal. The reason for the 60% response rate is simply due to genetics. Only 60% of these people have genetics that can respond and make these hair follicles immune.

                      In essence, it's a much better alternative to Fin that permanently makes your hair immune to MPB. Mix it with Histogen and you could get great results.
                      I really don't understand how forums members have suddenly decided that aderans "immunizes" hair follicles to MPB. That has never been demonstrated experimentally. There has been no data to suggest this is even remotely possible; it's merely hypothetical speculation. And far fetched speculation at that. There has been talk that the injected cells would incorporate in the follicle structure and "somehow" change the entire geno and phenotypic expression of all the cells in that follicle. This would be quite the feat! One without precedent. And there is really no scientifically valid explanation to explain how a few injected cells will change the genetics of an entire functioning organ such as a hair follicle.

                      In regards to Aderan's clinical trial, It would take many years beyond the scope of a traditional clinical trial to demonstrate that follicles have been immunized to mpb. Furthermore, it would require scientific measurements that are beyond what they are doing with their current trials. Such as following the progress of specific follicles and how they fare over time. So, i respectfully have to disagree with you. Aderans is not about immunization, they are, and i believe they've said so themselves, about follicle rejuvenation. Which oddly, is a position 100% opposite of what they declared earlier - in that they said rejuvenation is not possible and neogenisis is what they were doing.

                      But, with that said, i do think they are showing some results. Be interesting to see if it's compoundable. And then if you consider it combined with something like histogen and maybe a transplant, there could for the first time in history, be a treatment option that could restore a lot of hair.

                      Comment

                      • clandestine
                        Senior Member
                        • Aug 2011
                        • 2002

                        #41
                        Originally posted by Pate
                        RU will never reach market. Too unstable and the patents are too close to expiry, and too unsafe around women.
                        How dangerous is RU around women?

                        Comment

                        • Pate
                          Senior Member
                          • Sep 2011
                          • 417

                          #42
                          Only dangerous for pregnant women. There is some systemic absorption of RU and at least one of the metabolites of RU is antiandrogenic, which is doubly bad news.

                          CB on the other hand is quickly metabolised to an inactive molecule. It should be much safer around women, though you would still want to keep it away.

                          Comment

                          • clandestine
                            Senior Member
                            • Aug 2011
                            • 2002

                            #43
                            *****, would love for CB to come to market. Thanks for the reply by the way. Any idea what the expected timeline for CB is?

                            Comment

                            • Pate
                              Senior Member
                              • Sep 2011
                              • 417

                              #44
                              Probably 2017 for alopecia formulation, maybe 2016 if we're lucky.

                              The acne formulation they are aiming to get out by 2015, but I suspect 2016 is more realistic.

                              I never understand why they all want to try the acne formulation first. There are already treatments for acne and, while it can be distressing for some suffers for sure, severe acne in need of treatment isn't nearly as common as MPB. Surely MPB is an order of magnitude bigger market at least?

                              There are still some risks. The biggest ones for CB are that either Cosmo gets bought out (like happened with NEOSH) or the 'major multinational pharmaceutical company' they are partnered with decides it's not economic and sits on the patent til it expires, as is happening with RU.

                              They also still need to come up with an effective vehicle. They don't have one yet.

                              Comment

                              • clandestine
                                Senior Member
                                • Aug 2011
                                • 2002

                                #45
                                bump

                                10blox

                                Comment

                                Working...